Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Safety, pharmacokinetics and pharmacodynamics of a novel anti-asthmatic drug, XC8, in healthy probands.

Renner A, Romanova J, Ferko B, Schmutz H, Nebolsin V, Müller M, Badorrek P, Marth K, Pohl W.

Pulm Pharmacol Ther. 2019 Oct 6:101852. doi: 10.1016/j.pupt.2019.101852. [Epub ahead of print]

PMID:
31597083
2.

The study of oral fluid dynamic parameters on the background of pathological and physiological dental abrasion.

Kovalenko VV, Tkachenko IM, Nazarenko ZY, Brailko NM, Romanova JG, Sheshukova OV, Vodoriz YV.

Wiad Lek. 2019;72(7):1315-1319.

PMID:
31398162
3.

Molecular Design of pH-Sensitive Ru(II)-Polypyridyl Luminophores.

Romanova J, Sadik Y, Prabhath MRR, Carey JD, Jarowski PD.

J Phys Chem A. 2019 Jun 13;123(23):4921-4928. doi: 10.1021/acs.jpca.9b03019. Epub 2019 Jun 4.

PMID:
31117595
4.

A Novel Oral Glutarimide Derivative XC8 Suppresses Sephadex-Induced Lung Inflammation in Rats and Ovalbumin-induced Acute and Chronic Asthma in Guinea Pigs.

Ferko B, Romanova J, Rydlovskaya AV, Kromova TA, Proskurina OV, Amelina AN, Schmutz H, Renner A, Nebolsin VE.

Curr Pharm Biotechnol. 2019;20(2):146-156. doi: 10.2174/1389201020666190215103505.

PMID:
30767739
5.

Iron oxide nanoparticles - In vivo/in vitro biomedical applications and in silico studies.

Nedyalkova M, Donkova B, Romanova J, Tzvetkov G, Madurga S, Simeonov V.

Adv Colloid Interface Sci. 2017 Nov;249:192-212. doi: 10.1016/j.cis.2017.05.003. Epub 2017 May 3. Review.

PMID:
28499604
6.

PPV Polymerization through the Gilch Route: Diradical Character of Monomers.

Nikolić JD, Wouters S, Romanova J, Shimizu A, Champagne B, Junkers T, Vanderzande D, Van Neck D, Waroquier M, Van Speybroeck V, Catak S.

Chemistry. 2015 Dec 21;21(52):19176-85. doi: 10.1002/chem.201501900. Epub 2015 Nov 16.

PMID:
26568272
7.

A genetically adjuvanted influenza B virus vector increases immunogenicity and protective efficacy in mice.

Kittel C, Wressnigg N, Shurygina AP, Wolschek M, Stukova M, Romanovskaya-Romanko E, Romanova J, Kiselev O, Muster T, Egorov A.

Arch Virol. 2015 Oct;160(10):2525-34. doi: 10.1007/s00705-015-2525-9. Epub 2015 Jul 28.

PMID:
26215439
8.

The Role of Substituent Effects in Tuning Metallophilic Interactions and Emission Energy of Bis-4-(2-pyridyl)-1,2,3-triazolatoplatinum(II) Complexes.

Prabhath MR, Romanova J, Curry RJ, Silva SR, Jarowski PD.

Angew Chem Int Ed Engl. 2015 Jun 26;54(27):7949-53. doi: 10.1002/anie.201502390. Epub 2015 May 26.

PMID:
26015153
9.

Resonant Raman spectra of molecules with diradical character: multiconfigurational wavefunction investigation of neutral viologens.

Romanova J, Liégeois V, Champagne B.

Phys Chem Chem Phys. 2014 Oct 21;16(39):21721-31. doi: 10.1039/c4cp02977a. Epub 2014 Sep 8.

PMID:
25198792
10.

Regulation of 5-oxo-ETE synthesis by nitric oxide in human polymorphonuclear leucocytes upon their interaction with zymosan and Salmonella typhimurium.

Viryasova GM, Galkina SI, Gaponova TV, Romanova JM, Sud'ina GF.

Biosci Rep. 2014 May 23;34(3). pii: e00108. doi: 10.1042/BSR20130136.

11.

Egg- or cell culture-derived hemagglutinin mutations impair virus stability and antigen content of inactivated influenza vaccines.

Nakowitsch S, Waltenberger AM, Wressnigg N, Ferstl N, Triendl A, Kiefmann B, Montomoli E, Lapini G, Sergeeva M, Muster T, Romanova JR.

Biotechnol J. 2014 Mar;9(3):405-14. doi: 10.1002/biot.201300225. Epub 2013 Dec 10. Erratum in: Biotechnol J. 2014 Apr;9(4):585.

PMID:
24323790
12.

An inactivated, adjuvanted whole virion clade 2.2 H5N1 (A/Chicken/Astana/6/05) influenza vaccine is safe and immunogenic in a single dose in humans.

Sansyzbay AR, Erofeeva MK, Khairullin BM, Sandybayev NT, Kydyrbayev ZK, Mamadaliyev SM, Kassenov MM, Sergeeva MV, Romanova JR, Krivitskaya VZ, Kiselev OI, Stukova MA.

Clin Vaccine Immunol. 2013 Aug;20(8):1314-9. doi: 10.1128/CVI.00096-13. Epub 2013 Jun 26.

13.

Validation of the modified hemagglutination inhibition assay (mHAI), a robust and sensitive serological test for analysis of influenza virus-specific immune response.

Morokutti A, Redlberger-Fritz M, Nakowitsch S, Krenn BM, Wressnigg N, Jungbauer A, Romanova J, Muster T, Popow-Kraupp T, Ferko B.

J Clin Virol. 2013 Apr;56(4):323-30. doi: 10.1016/j.jcv.2012.12.002. Epub 2013 Jan 31.

PMID:
23375739
14.

Magnetostructural correlation for rational design of Mn(II) hybrid-spin complexes.

Ivanova A, Romanova J, Tadjer A, Baumgarten M.

J Phys Chem A. 2013 Jan 24;117(3):670-8. doi: 10.1021/jp312258j. Epub 2013 Jan 14.

PMID:
23256643
15.

Proteome analysis identified human neutrophil membrane tubulovesicular extensions (cytonemes, membrane tethers) as bactericide trafficking.

Galkina SI, Fedorova NV, Serebryakova MV, Romanova JM, Golyshev SA, Stadnichuk VI, Baratova LA, Sud'ina GF, Klein T.

Biochim Biophys Acta. 2012 Nov;1820(11):1705-14. doi: 10.1016/j.bbagen.2012.06.016. Epub 2012 Jul 2.

PMID:
22766193
16.

The effects of addition of mononucleotides on Sma nuc endonuclease activity.

Romanova J, Filimonova M.

ScientificWorldJournal. 2012;2012:454176. doi: 10.1100/2012/454176. Epub 2012 Apr 30.

17.

Absorption spectra of model single chains of conducting polyaniline.

Petrova J, Romanova J, Madjarova G, Ivanova A, Tadjer A.

J Phys Chem B. 2012 Jun 7;116(22):6543-52. doi: 10.1021/jp301814u. Epub 2012 May 23.

PMID:
22577886
18.

Involvement of red blood cells in the regulation of leukotriene synthesis in polymorphonuclear leucocytes upon interaction with Salmonella Typhimurium.

Golenkina EA, Galkina SI, Romanova JM, Lazarenko MI, Sud'ina GF.

APMIS. 2011 Sep;119(9):635-42. doi: 10.1111/j.1600-0463.2011.02786.x. Epub 2011 Jul 5.

PMID:
21851422
19.

Antimycotic-antibiotic amphotericin B promotes influenza virus replication in cell culture.

Roethl E, Gassner M, Krenn BM, Romanovskaya-Romanko EA, Seper H, Romanova J, Nakowitsch S, Sturlan S, Wolschek M, Sirotkin A, Kiselev O, Muster T, Egorov A.

J Virol. 2011 Nov;85(21):11139-45. doi: 10.1128/JVI.00169-11. Epub 2011 Aug 17.

20.

Zener tunneling in semiconductor superlattices.

Romanova JY, Demidov EV, Mourokh LG, Romanov YA.

J Phys Condens Matter. 2011 Aug 3;23(30):305801. doi: 10.1088/0953-8984/23/30/305801. Epub 2011 Jul 12.

PMID:
21747156
21.

Single HA2 mutation increases the infectivity and immunogenicity of a live attenuated H5N1 intranasal influenza vaccine candidate lacking NS1.

Krenn BM, Egorov A, Romanovskaya-Romanko E, Wolschek M, Nakowitsch S, Ruthsatz T, Kiefmann B, Morokutti A, Humer J, Geiler J, Cinatl J, Michaelis M, Wressnigg N, Sturlan S, Ferko B, Batishchev OV, Indenbom AV, Zhu R, Kastner M, Hinterdorfer P, Kiselev O, Muster T, Romanova J.

PLoS One. 2011 Apr 7;6(4):e18577. doi: 10.1371/journal.pone.0018577.

22.

Fully doped oligomers of emeraldine salt: polaronic versus bipolaronic configuration.

Petrova JN, Romanova JR, Madjarova GK, Ivanova AN, Tadjer AV.

J Phys Chem B. 2011 Apr 14;115(14):3765-76. doi: 10.1021/jp111914n. Epub 2011 Mar 21.

PMID:
21417472
23.

Mutations affecting the stability of the haemagglutinin molecule impair the immunogenicity of live attenuated H3N2 intranasal influenza vaccine candidates lacking NS1.

Nakowitsch S, Wolschek M, Morokutti A, Ruthsatz T, Krenn BM, Ferko B, Ferstl N, Triendl A, Muster T, Egorov A, Romanova J.

Vaccine. 2011 Apr 27;29(19):3517-24. doi: 10.1016/j.vaccine.2011.02.100. Epub 2011 Mar 12.

PMID:
21406268
24.

Membrane tubules attach Salmonella Typhimurium to eukaryotic cells and bacteria.

Galkina SI, Romanova JM, Bragina EE, Tiganova IG, Stadnichuk VI, Alekseeva NV, Polyakov VY, Klein T.

FEMS Immunol Med Microbiol. 2011 Feb;61(1):114-24. doi: 10.1111/j.1574-695X.2010.00754.x. Epub 2010 Nov 8.

25.

Bactericidal effects of non-thermal argon plasma in vitro, in biofilms and in the animal model of infected wounds.

Ermolaeva SA, Varfolomeev AF, Chernukha MY, Yurov DS, Vasiliev MM, Kaminskaya AA, Moisenovich MM, Romanova JM, Murashev AN, Selezneva II, Shimizu T, Sysolyatina EV, Shaginyan IA, Petrov OF, Mayevsky EI, Fortov VE, Morfill GE, Naroditsky BS, Gintsburg AL.

J Med Microbiol. 2011 Jan;60(Pt 1):75-83. doi: 10.1099/jmm.0.020263-0. Epub 2010 Sep 9.

PMID:
20829396
26.

A novel type of influenza vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1.

Wacheck V, Egorov A, Groiss F, Pfeiffer A, Fuereder T, Hoeflmayer D, Kundi M, Popow-Kraupp T, Redlberger-Fritz M, Mueller CA, Cinatl J, Michaelis M, Geiler J, Bergmann M, Romanova J, Roethl E, Morokutti A, Wolschek M, Ferko B, Seipelt J, Dick-Gudenus R, Muster T.

J Infect Dis. 2010 Feb 1;201(3):354-62. doi: 10.1086/649428.

PMID:
20039806
27.

Microbial alkaloid staurosporine induces formation of nanometer-wide membrane tubular extensions (cytonemes, membrane tethers) in human neutrophils.

Galkina SI, Stadnichuk VI, Molotkovsky JG, Romanova JM, Sud'ina GF, Klein T.

Cell Adh Migr. 2010 Jan-Mar;4(1):32-8. Epub 2010 Jan 14.

28.

An in-depth theoretical approach to the design of Cu(II) hybrid-spin magnets.

Romanova J, Miteva T, Ivanova A, Tadjer A, Baumgarten M.

Phys Chem Chem Phys. 2009 Nov 7;11(41):9545-55. doi: 10.1039/b908858j. Epub 2009 Aug 21.

PMID:
19830340
29.

Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on amlodipine monotherapy.

Schunkert H, Glazer RD, Wernsing M, Yen J, Macarie CE, Vintila MM, Romanova J.

Curr Med Res Opin. 2009 Nov;25(11):2655-62. doi: 10.1185/03007990903251193.

PMID:
19751115
30.

Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccine.

Romanova J, Krenn BM, Wolschek M, Ferko B, Romanovskaja-Romanko E, Morokutti A, Shurygina AP, Nakowitsch S, Ruthsatz T, Kiefmann B, König U, Bergmann M, Sachet M, Balasingam S, Mann A, Oxford J, Slais M, Kiselev O, Muster T, Egorov A.

PLoS One. 2009 Jun 19;4(6):e5984. doi: 10.1371/journal.pone.0005984.

31.

Nitric oxide-induced membrane tubulovesicular extensions (cytonemes) of human neutrophils catch and hold Salmonella enterica serovar Typhimurium at a distance from the cell surface.

Galkina SI, Romanova JM, Stadnichuk VI, Molotkovsky JG, Sud'ina GF, Klein T.

FEMS Immunol Med Microbiol. 2009 Jul;56(2):162-71. doi: 10.1111/j.1574-695X.2009.00560.x. Epub 2009 Apr 27.

32.

Development of a live-attenuated influenza B DeltaNS1 intranasal vaccine candidate.

Wressnigg N, Voss D, Wolff T, Romanova J, Ruthsatz T, Mayerhofer I, Reiter M, Nakowitsch S, Humer J, Morokutti A, Muster T, Egorov A, Kittel C.

Vaccine. 2009 May 11;27(21):2851-7. doi: 10.1016/j.vaccine.2009.02.087. Epub 2009 Mar 11.

PMID:
19366569
33.

Unprecedented Route to Ordered Polyaniline: Direct Synthesis of Highly Crystalline Fibrillar Films with Strong π-π Stacking Alignment.

Gospodinova N, Ivanov DA, Anokhin DV, Mihai I, Vidal L, Brun S, Romanova J, Tadjer A.

Macromol Rapid Commun. 2009 Jan 2;30(1):29-33. doi: 10.1002/marc.200800434. Epub 2008 Sep 30.

PMID:
21706534
34.

Fusion of enveloped virus nanoparticles with polyelectrolyte-supported lipid membranes for the design of bio/nonbio interfaces.

Fischlechner M, Reibetanz U, Zaulig M, Enderlein D, Romanova J, Leporatti S, Moya S, Donath E.

Nano Lett. 2007 Nov;7(11):3540-6. Epub 2007 Oct 26.

PMID:
17960947
35.

The fight against new types of influenza virus.

Romanova J.

Biotechnol J. 2006 Dec;1(12):1381-92. Review.

PMID:
17124703
36.

Live attenuated influenza virus expressing human interleukin-2 reveals increased immunogenic potential in young and aged hosts.

Ferko B, Kittel C, Romanova J, Sereinig S, Katinger H, Egorov A.

J Virol. 2006 Dec;80(23):11621-7. Epub 2006 Sep 13.

37.

Mycobacterium tuberculosis-susceptible I/St mice develop severe disease following infection with taxonomically distant bacteria, Salmonella enterica and Chlamydia pneumoniae.

Nesterenko LN, Balunets DV, Tomova AS, Romanova JM, Alyapkina JS, Zigangirova NA, Kapina MA, Kondratieva EV, Pichugin AV, Majorov KB, Apt AS.

Clin Exp Immunol. 2006 Oct;146(1):93-100.

38.

Influenza virus NS vectors expressing the mycobacterium tuberculosis ESAT-6 protein induce CD4+ Th1 immune response and protect animals against tuberculosis challenge.

Sereinig S, Stukova M, Zabolotnyh N, Ferko B, Kittel C, Romanova J, Vinogradova T, Katinger H, Kiselev O, Egorov A.

Clin Vaccine Immunol. 2006 Aug;13(8):898-904.

39.

Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 protein.

Stukova MA, Sereinig S, Zabolotnyh NV, Ferko B, Kittel C, Romanova J, Vinogradova TI, Katinger H, Kiselev OI, Egorov A.

Tuberculosis (Edinb). 2006 May-Jul;86(3-4):236-46.

PMID:
16677861
40.

Search for additional influenza virus to cell interactions.

Rapoport EM, Mochalova LV, Gabius HJ, Romanova J, Bovin NV.

Glycoconj J. 2006 Feb;23(1-2):115-25.

PMID:
16575529
41.

Generation of an influenza A virus vector expressing biologically active human interleukin-2 from the NS gene segment.

Kittel C, Ferko B, Kurz M, Voglauer R, Sereinig S, Romanova J, Stiegler G, Katinger H, Egorov A.

J Virol. 2005 Aug;79(16):10672-7.

42.
43.

Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes.

Ferko B, Stasakova J, Romanova J, Kittel C, Sereinig S, Katinger H, Egorov A.

J Virol. 2004 Dec;78(23):13037-45.

44.

Specificity of neuraminidase activity from influenza viruses isolated in different hosts tested with novel substrates.

Katinger D, Mochalova L, Chinarev A, Bovin N, Romanova J.

Arch Virol. 2004 Nov;149(11):2131-40. Epub 2004 Jun 30.

PMID:
15503202
45.

Rescue of influenza virus expressing GFP from the NS1 reading frame.

Kittel C, Sereinig S, Ferko B, Stasakova J, Romanova J, Wolkerstorfer A, Katinger H, Egorov A.

Virology. 2004 Jun 20;324(1):67-73.

46.

Live cold-adapted influenza A vaccine produced in Vero cell line.

Romanova J, Katinger D, Ferko B, Vcelar B, Sereinig S, Kuznetsov O, Stukova M, Erofeeva M, Kiselev O, Katinger H, Egorov A.

Virus Res. 2004 Jul;103(1-2):187-93.

PMID:
15163508
47.

Effect of a single mutation in neuraminidase on the properties of Influenza B virus isolates.

Katinger D, Romanova J, Ferko B, Fekete H, Egorov A.

Arch Virol. 2004 Jan;149(1):173-81. Epub 2003 Sep 22.

PMID:
14689282
48.

Receptor-binding properties of modern human influenza viruses primarily isolated in Vero and MDCK cells and chicken embryonated eggs.

Mochalova L, Gambaryan A, Romanova J, Tuzikov A, Chinarev A, Katinger D, Katinger H, Egorov A, Bovin N.

Virology. 2003 Sep 1;313(2):473-80.

49.

Distinct host range of influenza H3N2 virus isolates in Vero and MDCK cells is determined by cell specific glycosylation pattern.

Romanova J, Katinger D, Ferko B, Voglauer R, Mochalova L, Bovin N, Lim W, Katinger H, Egorov A.

Virology. 2003 Mar 1;307(1):90-7.

50.

Resuscitation of Salmonella enterica serovar typhimurium and enterohemorrhagic Escherichia coli from the viable but nonculturable state by heat-stable enterobacterial autoinducer.

Reissbrodt R, Rienaecker I, Romanova JM, Freestone PP, Haigh RD, Lyte M, Tschäpe H, Williams PH.

Appl Environ Microbiol. 2002 Oct;68(10):4788-94.

Supplemental Content

Loading ...
Support Center